Protagonist Therapeutics
PTGX
PTGX
128 hedge funds and large institutions have $875M invested in Protagonist Therapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 48 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
+36
Holders Change %
+39.13%
% of All Funds
2.27%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
46
Increased
48
Reduced
21
Closed
10
Calls
$214K
Puts
$901K
Net Calls
-$687K
Net Calls Change
-$681K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
IA
126
IFP Advisors
Tampa,
Florida
| $1K | +$1K | +40 | New |
|
|
SPIA
127
Steward Partners Investment Advisory
New York
| $1K | +$1K | +40 | New |
|
|
AIG
128
American International Group
New York
| $369 | +$4 | +188 | +1% |
|
|
SI
129
Sofinnova Investments
Menlo Park,
California
| – | -$6.99M | -357,769 | Closed |
|
130
Invesco
Atlanta,
Georgia
| – | -$3.7M | -189,232 | Closed |
|
131
Arrowstreet Capital
Boston,
Massachusetts
| – | -$1.31M | -66,928 | Closed |
|
|
MAM
132
Martingale Asset Management
Boston,
Massachusetts
| – | -$855K | -43,700 | Closed |
|
|
WG
133
Winton Group
London,
United Kingdom
| – | -$642K | -32,854 | Closed |
|
|
BRA
134
Blue Rock Advisors
Wayzata,
Minnesota
| – | -$590K | -30,146 | Closed |
|
|
FIM
135
Freedom Investment Management
Hartford,
Connecticut
| – | -$212K | -10,867 | Closed |
|
136
SG Americas Securities
New York
| – | -$106K | -5,420 | Closed |
|
137
Rockefeller Capital Management
New York
| – | -$39K | -2,000 | Closed |
|
|
QT
138
Quantbot Technologies
New York
| – | -$5K | -300 | Closed |
|